PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|11|1|4-13

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.11, Iss.1, 2018-04, pp. : 4-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of F-18 Choline PET and PET/CT in Prostate Cancer

By Kohlfürst S.   Malle P.   Igerc I.   Gallowitsch H. J.   Lind P.  

Imaging Decisions MRI, Vol. 13, Iss. 3-4, 2009-0 ,pp. : 97-103

Blackwell Publishing

Access to resources Recommend Favorite

Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 19-31

Bentham Science Publishers

Access to resources Recommend Favorite

PET Imaging with [68Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [18F]Fluorodeoxyglucose and [18F]Fluoroethylcholine

By  

Current Cancer Drug Targets, Vol. 14, Iss. 4, 2014-05 ,pp. : 371-379

Bentham Science Publishers

Access to resources Recommend Favorite

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

By  

Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. : 195-202

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Applications of Choline PET/CT in Brain Tumors

By  

Current Pharmaceutical Design, Vol. 21, Iss. 1, 2015-01 ,pp. : 121-127

Bentham Science Publishers

Access to resources Recommend Favorite